StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by kinpinon Feb 28, 2019 10:30am

67 Views

Post# 29422674

RE:RE:RE:HURRY up !!!

I legit believe in this company. The more I read the more I am falling in love with it. We are talking about top scientists in the word with joined forces. James is going to make a lot of people rich here. A lot people holding bags at .02 to 0.04 sold and made a profit. The newcomers who bought in at 0.10 know something that we dont know yet.

I wish I can double down but I put everything I have already.

they went from 8 million net loss to 1.something million net loss after.

They almost guaranteed that by end of 2019 they will 30 million plus.. and with aristotle they said 2 billion.

Bullboard Posts

Eminent acquires promising Nevada gold project